Meitheal Pharmaceuticals, Inc recalls Cetrorelix Acetate for Injection (Kit)
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Defective Delivery System: Missing or duplicated needles within the injection kit
- Products
-
- Cetrorelix Acetate for Injection (Kit)
- Where it was sold
-
U.S. Nationwide
Nationwide
- Units affected
- 16,477 kits
- About this recall
- Cetrorelix Acetate for Injection (Kit), 0.25 mg per vial, Single-Dose Kit, Rx Only, Mfd. for: Meitheal Pharmaceuticals, Chicago, IL NDC 71288-558-90.